Boehringer Ingelheim Venture Fund

United States
cb
Firm Location:United States • Connecticut • San Francisco, California • Cambridge, Massachusetts • Hong Kong • Shanghai • San Francisco Bay Area • Germany
Investor Firms That Co-Invest with Boehringer Ingelheim Venture Fund
Insight PartnersSoffinova PartnersT1D FundParkwalk AdvisorsDistributed VenturesVerve Ventures
Boehringer Ingelheim Venture Fund Team
Photo of Yifang Cui, Investor at Boehringer Ingelheim Venture Fund
Yifang Cui
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Germany
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT
to see your intro paths to Yifang
Photo of Niklas Czeloth, Investor at Boehringer Ingelheim Venture Fund
Niklas Czeloth
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Germany
Investors in Pharmaceuticals, Investors in Pharmaceuticals
to see your intro paths to Niklas
Photo of Kanad Das, Investor at Boehringer Ingelheim Venture Fund
Kanad Das
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in San Francisco (CA)
Investors in BioTech, Investors in BioTech, Investors in Pharmaceuticals, Investors in Pharmaceuticals, Investors in San Francisco Bay Area (Other Lists)
to see your intro paths to Kanad
Photo of Alexander Ehlgen, Investor at Boehringer Ingelheim Venture Fund
Alexander Ehlgen
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Israel, Investors in Europe
Investors in Consumer Health, Investors in Consumer Health, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Pharmaceuticals, Investors in Pharmaceuticals
to see your intro paths to Alexander
Photo of Mia Hu, Associate at Boehringer Ingelheim Venture Fund
Mia Hu
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Hong Kong
Investors in BioTech, Investors in BioTech, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Medical Devices, Investors in Medical Devices, Investors in Pharmaceuticals, Investors in Pharmaceuticals
to see your intro paths to Mia
Photo of Frank Kalkbrenner, Investor at Boehringer Ingelheim Venture Fund
Frank Kalkbrenner
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Germany
Investors in BioTech, Investors in BioTech
to see your intro paths to Frank
Photo of Julia Kaufman, Investor at Boehringer Ingelheim Venture Fund
Julia Kaufman
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in United States
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT
to see your intro paths to Julia
Photo of Sebastian Kreuz, Managing Director at Boehringer Ingelheim Venture Fund
Sebastian Kreuz
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Germany
Investors in Pharmaceuticals, Investors in Pharmaceuticals
to see your intro paths to Sebastian
Photo of Hongmei Li, Investor at Boehringer Ingelheim Venture Fund
Hongmei Li
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Shanghai
Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT
to see your intro paths to Hongmei
Photo of Debbie Lin, Investor at Boehringer Ingelheim Venture Fund
Debbie Lin
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Boston / New England (Other Lists), Investors in Consumer Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health IT, Investors in Pharmaceuticals
to see your intro paths to Debbie
Photo of Philipp Mueller, Investor at Boehringer Ingelheim Venture Fund
Philipp Mueller
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Germany
Investors in BioTech, Investors in BioTech, Investors in Pharmaceuticals, Investors in Pharmaceuticals
to see your intro paths to Philipp
Photo of Stefan Pflanz, Investor at Boehringer Ingelheim Venture Fund
Stefan Pflanz
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in San Francisco (CA)
to see your intro paths to Stefan
Photo of Mark Ralph, Investor at Boehringer Ingelheim Venture Fund
Mark Ralph
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Boston (MA)
Investors in Consumer Health, Investors in Consumer Health, Investors in Digital Health, Investors in Digital Health, Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT, Investors in Pharmaceuticals, Investors in Pharmaceuticals
to see your intro paths to Mark
Photo of Oliver Reuss, Investor at Boehringer Ingelheim Venture Fund
Oliver Reuss
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Germany
Investors in Health & Hospital Services, Investors in Health & Hospital Services, Investors in Health IT, Investors in Health IT
to see your intro paths to Oliver
Photo of Fei Shen, Managing Director at Boehringer Ingelheim Venture Fund
Fei Shen
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Cambridge (MA)
Investors in BioTech, Investors in BioTech, Investors in Boston / New England (Other Lists), Investors in Pharmaceuticals, Investors in Pharmaceuticals
to see your intro paths to Fei
Photo of Johannes Zanzinger, Investor at Boehringer Ingelheim Venture Fund
Johannes Zanzinger
Sweet spot: $8.5M
Range: $3.3M - $17.0M
Investors in Germany
Investors in Pharmaceuticals, Investors in Pharmaceuticals
to see your intro paths to Johannes